Trial Shows InSightec's Tremor Therapy Could Improve With Better Imaging

Results of a small clinical trial of tractography-based ventral intermediate nucleus-targeting suggest this MRI-based imaging approach could help improve the outcomes of focused ultrasound brain intervention with InSightec's Exablate Neuro system for the noninvasive treatment of essential tremor.

A novel approach to magnetic resonance imaging of the brain could make InSightec Ltd.'s Exablate Neuro focused ultrasound system more effective and safer for the treatment of neurological disorders, according to results of a small feasibility trial.

Essential tremor is a unique neurological condition caused by a deficiency of a brain chemical called gamma-aminobutyric acid (GABA) or a defect in the GABA receptors, Vibhor Krishna at Ohio...

More from R&D

More from Business

Edwards Lifesciences Holds 2025 EPS Outlook Despite Tariff Headwind

 
• By 

The brunt of the tariff exposure stems from Singapore and Costa Rica, which together account for an estimated 70% to 80% of the tariff-related cost burden. Less than 10% of the exposure is tied to China.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.